Product NDC: | 0409-4011 |
Proprietary Name: | Verapamil Hydrochloride |
Non Proprietary Name: | VERAPAMIL HYDROCHLORIDE |
Active Ingredient(s): | 2.5 mg/mL & nbsp; VERAPAMIL HYDROCHLORIDE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-4011 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA070738 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110325 |
Package NDC: | 0409-4011-01 |
Package Description: | 5 AMPULE in 1 CONTAINER (0409-4011-01) > 2 mL in 1 AMPULE |
NDC Code | 0409-4011-01 |
Proprietary Name | Verapamil Hydrochloride |
Package Description | 5 AMPULE in 1 CONTAINER (0409-4011-01) > 2 mL in 1 AMPULE |
Product NDC | 0409-4011 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | VERAPAMIL HYDROCHLORIDE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20110325 |
Marketing Category Name | ANDA |
Labeler Name | Hospira, Inc. |
Substance Name | VERAPAMIL HYDROCHLORIDE |
Strength Number | 2.5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC] |